Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Silo Pharma (SILO) over the last 11 years, with Q2 2025 value amounting to $410300.0.

  • Silo Pharma's Change in Acquisitions & Divestments fell 5892.61% to $410300.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 6136.5%. This contributed to the annual value of $1.1 million for FY2024, which is 7228.62% down from last year.
  • According to the latest figures from Q2 2025, Silo Pharma's Change in Acquisitions & Divestments is $410300.0, which was down 5892.61% from $905353.0 recorded in Q1 2025.
  • In the past 5 years, Silo Pharma's Change in Acquisitions & Divestments registered a high of $2.3 million during Q4 2023, and its lowest value of -$86707.0 during Q4 2022.
  • For the 5-year period, Silo Pharma's Change in Acquisitions & Divestments averaged around $601505.2, with its median value being $280344.5 (2024).
  • In the last 5 years, Silo Pharma's Change in Acquisitions & Divestments tumbled by 134000.0% in 2021 and then soared by 270189.14% in 2023.
  • Over the past 5 years, Silo Pharma's Change in Acquisitions & Divestments (Quarter) stood at -$62000.0 in 2021, then tumbled by 39.85% to -$86707.0 in 2022, then soared by 2701.89% to $2.3 million in 2023, then plummeted by 55.72% to $998931.0 in 2024, then tumbled by 58.93% to $410300.0 in 2025.
  • Its last three reported values are $410300.0 in Q2 2025, $905353.0 for Q1 2025, and $998931.0 during Q2 2024.